HIV myelopathy, peripheral neuropathy, and myopathy

Clinical Neurovirology

Volumn , Issue , 2003, Pages 277-296

  Estanislao, Lydia ^a   Geraci, Anthony ^a   Simpson, David M ^a   Di Rocco, Alessandro ^b  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 65549131416     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (135)

1. Snider, W.; Simpson, D.M.; Nielsen, S.; Metroka, C.; Posner, J. Neurological complications of acquired immunodeficiency syndrome: analysis of 50 patients. Ann Neurol. 1983, 14, 403–418.
2. Petito, C.K.; Navia, B.A.; Cho, E.S.; Jordan, B.D.; George, D.C.; Price, R.W. Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1985, 312(14), 874–829.
3. Artigas, J.; Grosse, G.; Niedobitek, F. Vacuolar myelopathy in AIDS: a morphological analysis. Pathol Res Pract. 1990, 186, 228–237.
4. Dal Pan, G.J.; Glass, J.D.; McArthur, J.C. Clinicopathologic correlations of HIV-1-associated vacuolar myelopathy: an autopsy-based case-control study. Neurology. 1994, 44(11), 2159–2164.
5. Lang, W.; Miklossy, J.; Deruaz, J.; Pizzolato, G.; Probst, A.; Schaffner, T. Neuropathology of the acquired immunodeficiency syndrome: a report of 135 consecutive autopsy cases from Switzerland. Acta Neuropathol (Berl). 1989, 77, 379–390.
6. Chong, J.; Di Rocco, A.; Tagliati, M.; Danisi, F.; Simpson, D.M.; Atlas, S.W. MR findings in AIDS-associated myelopathy. AJNR Am J Neuroradiol. 1999, 20(8), 1412–1416.
7. Overhage, J.; Greist, A.; Brown, D. Conus medullaris syndrome. Am J Med. 1990, 89, 814–815.
8. Tucker, T.; Dix, R.; Katzen, C.; Davis, R.; Schmidley, J. CMV and HSV ascending myelitis in a patient with AIDS. Ann of Neurol. 1985, 18, 74–79.
9. Tagliati, M.; Di Rocco, A.; Danisi, F.; Simpson, D. The role of somatosensory evoked potentials in the diagnosis of AIDS-associated myelopathy. Neurology. 2000, 54, 1477–1482.
10. Jakobsen, J.; Smith, T.; Gaub, J.; Helweg-Larsen, S.; Trojaborg, W. Progressive neurological dysfunction during latent HIV infection. Br Med J. 1989, 299, 225–228.
11. Pierelli, F.; Garrubba, C.; Tilia, G.; Parisi, L.; Fattapposta, F.; Pozzessere, G.; Soldati, G.; Stanzione, P.; D’Offizi, G.; Mezzaroma, I. Multimodal evoked potentials in HIV-1-seropositive patients: relationship between the immune impairment and the neurophysiological function. Acta Neurol Scand. 1996, 93(4), 266–271.
12. Simpson, D.; Tagliati, M. Neurological manifestations of HIV infection. Ann Intern Med. 1994, 121, 769–785.
13. Tan, S.; Guiloff, R.; Scaravilli, F. AIDS-associated vacuolar myelopathy. A morphometric study. Brain. 1995, 118, 1247–1261.
14. Goldstick, L.; Mandybur, T.; Bode, R. Spinal cord degeneration in AIDS. Neurology. 1985, 35, 103–106.
15. Budka, H. Human immunodeficiency virus (HIV) envelope and core proteins in CNS tissues of patients with the acquired immune deficiency syndrome (AIDS). Acta Neuropathol (Berlin). 1990, 79, 611–619.
16. Eilbott, D.; Peress, N.; Burger, H. Human immunodeficiency virus type 1 in spinal cords of acquired immunodeficiency syndrome patients with myelopathy: expression and replication in macrophages. Proc Natl Acad Sci USA. 1989, 86, 3337–3341.
17. Kure, K.; Llena, J.; Lyman, W.; Soreiro, R.; Weidenheim, K.; Hirano, A.; Dickson, D. Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric and fetal brains. Hum Pathol. 1991, 22, 700–710.
18. Petito, C.K.; Vecchio, D.; Chen, Y.T. HIV antigen and DNA in AIDS spinal cords correlate with macrophage infiltration but not with vacuolar myelopathy. J Neuropathol Exp Neurol. 1994, 53(1), 86–94.
19. Rosenblum, M.; Scheck, A.C.; Cronin, K.; Brew, B.J.; Khan, A.; Paul, M.; Price, R.W. Dissociation of AIDS-related vacuolar myelopathy and productive HIV-1 infection of the spinal cord. Neurology. 1989, 39(7), 892–896.
20. Geraci, A.; Di Rocco, A.; Liu, M.; Werner, P.; Tagliati, M.; Godbold, J.; Simpson, D.; Morgello, S. AIDS myelopathy is not associated with elevated HIV viral load in cerebrospinal fluid. Neurology. 2000, 55(3), 440–442.
21. Tan, S.V.; Guiloff, R.J. Hypothesis on the pathogenesis of vacuolar myelopathy, dementia, and peripheral neuropathy in AIDS [see comments]. J Neurol Neurosurg Psychiatry. 1998, 65(1), 23–28.
22. Surtees, R.; Hyland, K.; Smith, I. Central nervous system methyl group metabolism in children with neurological complications of HIV infection. Lancet. 1990, 335(1), 619–621.
23. Castagna, A.; Le Grazie, C.; Accordini, A.; Giulidori, P.; Cavalli, G.; Bottiglieri, T.; Lazzarin, A. Cerebrospinal fluid S-adenosylmethionine (SAMe) and glutathione concentrations in HIV infection: effect of parenteral treatment with SAMe. Neurology. 1995, 45(9), 1678-1683.
24. DiRocco, A.; Tagliati, M.; Danisi, F.; Dorfman, D.; Moise, J.; Simpson, D. L-Methionine for AIDS-associated vacuolar myelopathy. Neurology. 1998, 51, 266–268.
25. Di Rocco, A. Diseases of the spinal cord in human immunodeficiency virus infection. Semin Neurol. 1999, 19(2), 151–155.
26. Snider, W.; Simpson, D.; Nielsen, S. Neurologic complications of acquired immunodeficiency syndrome; analysis of 50 patients. Ann Neurol. 1983, 14, 403–418.
27. Kieburtz, K.; Giang, D.; Schiffer, R.; Vakil, N. Abnormal vitamin B12 metabolism in human immunodeficiency virus infection: association with neurologic dysfunction. Arch Neural. 1991, 48(3), 312–314.
28. Dal Pan, G.; Berger, J. Spinal cord disease in human immunodeficiency virus infection. In:; Berger, J., Levy, R., Eds. AIDS and the Nervous System; Lippincott-Raven: Philadelphia, 1997, 173–187.
29. Oksenhendler, E.; Ferchal, F.; Cadranel, J.; Sauvageon-Martre, H.; Clauvel, J. Zidovudine for HIV-related myelopathy. Am J Med. 1990, 88(5N), 65N–66N.
30. Yarchoan, R.; Berg, G.; Brouwers, P. Response of immunodeficiency virus-associated neurological disease to 3′-azido-3′-deoxythymidine. Lancet. 1987, 1, 132–135.
31. Staudinger, R.; Henry, K. Remission of HIV myelopathy after highly active antiretroviral therapy. Neurology. 2000, 54, 267–268.
32. Di Rocco, A.; Geraci, A.; Tagliati, M. Remission of HIV myelopathy after highly active antiretroviral therapy [letter]. Neurology. 2000, 55, 456.
33. Geraci, A.; Di Rocco, A. Anti-HIV therapy. AIDS. 2000, 14(13), 2059–2061.
34. Bailey, R.O.; Baltch, A.L.; Venkatesh, R.; Singh, J.K.; Bishop, M.B. Sensory motor neuropathy associated with AIDS. Neurology. 1988, 38(6), 886–891.
35. Cornblath, D.R.; McArthur, J.C. Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex. Neurology. 1988, 38(5), 794–796.
36. de la Monte, S.M.; Gabuzda, D.H.; Ho, D.D.; Brown, R.H., Jr; Hedley-Whyte, E.T.; Schooley, R.T.; Hirsch, M.S.; Bhan, A.K. Peripheral neuropathy in the acquired immunodeficiency syndrome. Ann Neurol. 1988, 23(5), 485–492.
37. Janssen, R.S.; Saykin, A.J.; Kaplan, J.E.; Spira, T.J.; Pinsky, P.F.; Sprehn, G.C.; Hoffman, J.C.; Mayer, W.B.; Schonberger, L.B. Neurological complications of human immunodeficiency virus infection in patients with lymphadenopathy syndrome. Ann Neurol. 1988, 23(1), 49–55.
38. Lange, D.J.; Britton, C.B.; Younger, D.S.; Hays, A.P. The neuromuscular manifestations of human immunodeficiency virus infections. Arch Neurol. 1988, 45(10), 1084–1088.
39. Leger, J.M.; Bouche, P.; Bolgert, F.; Chaunu, M.P.; Rosenheim, M.; Cathala, H.P.; Gentilini, M.; Hauw, J.J.; Brunet, P. The spectrum of polyneuropathies in patients infected with HIV. J Neurol Neurosurg Psychiatry. 1989, 52(12), 1369–1374.
40. Levy, R.; Bredesen, D.; Rosenblum, M. Neurological manifestations of the acquired immunodeficiency syndrome: experience at UCSF and review of the literature. J Neurosurg. 1985, 62, 475–495.
41. Mah, V.; Vartavarian, L.M.; Akers, M.A.; Vinters, H.V. Abnormalities of peripheral nerve in patients with human immunodeficiency virus infection. Ann Neurol. 1988, 24(6), 713–717.
42. So, Y.T.; Holtzman, D.M.; Abrams, D.I.; Olney, R.K. Peripheral neuropathy associated with acquired immunodeficiency syndrome. Prevalence and clinical features from a population based survey. Arch Neurol. 1988, 45(9), 945–948.
43. Bacellar, H.; Munoz, A.; Miller, E.N.; Cohen, B.A.; Besley, D.; Selnes, O.A.; Becker, J.T.; McArthur, J.C. Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985–1992. Neurology. 1994, 44(10), 1892–1900.
44. Tagliati, M.; Grinnell, J.; Godbold, J.; Simpson, D.M. Peripheral nerve function in HIV infection: clinical, electrophysiologic, and laboratory findings. Arch Neurol. 1999, 56(1), 84–89.
45. Simpson, D.; Cohen, J.; Sivak, M. Neuromuscular complications in association with acquired immunodeficiency syndrome. Ann Neurol. 1985, 18, 160.
46. Griffin, J.W.; Crawford, T.O.; Tyor, W.R., et al. Predominantly sensory neuropathy in AIDS: Distal axonal degeneration and unmyelinated fiber loss. Neurology. 1991, 41(suppl 1), 374.
47. Lipkin, W.I.; Parry, G.; Kiprov, D.; Abrams, D. Inflammatory neuropathy in homosexual men with lymphadenopathy. Neurology. 1985, 35(10), 1479–1483.
48. Grafe, M.; Wiley, C. Spinal cord and peripheral nerve pathology in AIDS: the roles of cytomegalovirus and human immunodeficiency virus. Ann of Neurol. 1989, 25, 561–566.
49. Rance, N.E.; McArthur, J.C.; Cornblath, D.R.; Landstrom, D.L.; Griffin, J.W.; Price, D.L. Gracile tract degeneration in patients with sensory neuropathy and AIDS. Neurology. 1988, 38(2), 265–271.
50. Apostolski, S.; McAlarney, T.; Quattrini, A.; Levison, S.W.; Rosoklija, G.; Lugaressi, A.; Corbo, M.; Sadiq, S.A.; Lederman, S.; Hays, A.P. The gp120 glycoprotein of human immunodeficiency virus type 1 binds to sensory ganglion neurons. Ann Neurol. 1993, 34(6), 855–863.
51. Wesselingh, S.; Glass, J.; McArthur, J.; Griffin, J.; Griffin, D. Cytokine dysregulation in HIV-associated neurological disease. Adv Neuroimmunol. 1994, 4(3), 199–206.
52. Tyor, W.R.; Wesselingh, S.L.; Griffin, J.W.; McArthur, J.C.; Griffin, D.E. Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy. J Acquir Immune Defic Syndr Hum Retrovirol. 1995, 9(4), 379–388.
53. Yoshioka, M.; Shapshak, P.; Srivastava, A.K.; Stewart, R.V.; Nelson, S.J.; Bradley, W.G.; Berger, J.R.; Rhodes, R.H.; Sun, N.C.; Nakamura, S. Expression of HIV-1 and interleukin- 6 in lumbosacral dorsal root ganglia of patients with AIDS [published erratum appears in. Neurology]. Neurology. 1994, 44(6), 1120–1130.
54. Petratos, S.; Turnbull, V.; Papadopoulos, R. Antibodies against peripheral myelin glycolipids in people with HIV infection. Immunol Cell Biol. 1998, 76, 535–541.
55. Petratos, S.; Turnbull, V.; Papadopoulos, R. High titer anti-sulfatide antibodies in HIV-infected individuals. Neuroreport. 1999, 10, 2557–2562.
56. Petratos, S.; Turnbull, V.; Papadopoulos, R. Peripheral nerve binding patterns of anti-sulphatide antibodies in HIV- infected individuals. Neuroreport. 1999, 10, 1659–1664.
57. Fuller, G.N.; Jacobs, J.M.; Guiloff, R.J. Association of painful peripheral neuropathy in AIDS with cytomegalovirus infection [see comments]. Lancet. 1989, 2(8669), 937–941.
58. Moyle, G.J.; Sadler, M. Peripheral neuropathy with nucleoside antiretrovirals: risk factors, incidence and management. Drug Saf. 1998, 19(6), 481–494.
59. Garcia, G.; Smith, C. Adenosine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B: a randomized, double-blinded, placebo-controlled trial. Ann Intern Med. 1987, 107, 278–285.
60. Yarchoan, R.; Perno, C. Phase I studies of 2′,3′-deoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine. Lancet. 1988, 1, 76–81.
61. Merigan, T.; Skowron, G. Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections. Ann Intern Med. 1989, 110, 189–194.
62. Cooley, T.; Kunches, L. Once-daily administration of 2′3′-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. N Engl J Med. 1990, 322, 1340–1345.
63. Lambert, J.; Seidlin, M. Dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex: results of phase I trial. N Engl J Med. 1990, 322, 1333–1340.
64. Browne, M.J.; Mayer, K.H.; Chafee, S.B.; Dudley, M.N.; Posner, M.R.; Steinberg, S.M.; Graham, K.K.; Geletko, S.M.; Zinner, S.H.; Denman, S.L. 2′,3′-Didehydro-3′-deoxythymidine (d4T) in patients with AIDS or AIDS- related complex: a phase I trial. J Infect Dis. 1993, 167(1), 21–29.
65. Cooney, D.; Dalal, M. Initial studies on the cellular pharmacology of 2′3′-dideoxycytidine, an inhibitor of HTLV-III infectivity. Biochem Pharmacol. 1986, 35, 2065–2068.
66. Pezeshkpour, G.; Krarup, C. Peripheral neuropathy in mitochondrial disease. J Neurol Sci. 1987, 77, 285–304.
67. Balzarini, J.; Herdewlin, P. Differential patterns of intracellular metabolism of 2′3′-dideoxythymidine and 3′-azido-2′3′-dideoxythymidine, two potent anti-human immunodeficiency virus compounds. J Biol Chem. 1989, 264, 6127–6133.
68. Chen, C.H.; Vazquez-Padua, M.; Cheng, Y.C. Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity. Mol Pharmacol. 1991, 39(5), 625–628.
69. Chen, C.; Cheng, Y. Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2′3′-dideoxycytidine. J Biol Chem. 1989, 264, 11934–11937.
70. Martin, J.; Brown, C. Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis. Antimicrob Agents Chemother. 1994, 38, 2743–2749.
71. Cui, L.; Locatelli, L. Effect of nucleoside analogs on neurite regeneration and mitochondrial DNA synthesis in PC-12 cells. J Pharmacol Exp Ther. 1997, 280, 1228–1234.
72. Gasnault, J.; Pinganaud, C.; Kousignian, P. Subacute ascendant polyneuropathy revealing a nucleoside-induced mitochondrial cytopathy–: Lisbon: Portugal, 1999.
73. Angelucci, L.; Ramacci, M.; Taglialatela, G. Nerve growth factor binding in aged rat central nervous system: effect of acetyl-L-carnitine. J Neurosci Res. 1988, 20, 491–496.
74. Colucci, W.; Gandour, R. Carnitine acetyltransferase: a review of its biology, enzymology and bioorganic chemistry. Bioorg Chem. 1988, 16, 307–334.
75. Famularo, G.; Moretti, S.; Marcellini, S.; Trinchieri, V.; Tzantzoglou, S.; Santini, G.; Longo, A.; De Simone, C. Acetyl-carnitine deficiency in AIDS patients with neurotoxicity on treatment with antiretroviral nucleoside analogues. AIDS. 1997, 11(2), 185–190.
76. Simpson, D.; Katzenstein, D.; Haidichi, B., et al. and the AIDS Clinical Trials Group Protocol 291/860 Study Team. Plasma carnitine in HIV-associated neuropathy. AIDS. 2001, 15(16), 2207–2208.
77. Simpson, D.M.; Tagliati, M.; Ramcharitar, S. Neurologic complications of AIDS: new concepts and treatments. Mt Sinai J Med. 1994, 61(6), 484–491.
78. Simpson, D.; Tagliati, M. Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection. J AIDS. 1995, 9, 153–161.
79. Simpson, D.M.; Olney, R.; McArthur, J.C.; Khan, A.; Godbold, J.; Ebel-Frommer, K. A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy [see comments]. Neurology. 2000, 54(11), 2115–2119.
80. Mellick, G.; Mellick, L. Reflex sympathetic dystrophy treated with gabapentin. Arch Phys Med Rehab. 1997, 78, 89–105.
81. Rosner, H.; Rubin, L.; Kestenbaum, A. Gabapentin adjunctive therapy in neuropathic pain states. Clin J Pain. 1996, 12(1), 56–8.
82. Simpson, D. Neurologic complications of HIV: Diagnosing and Managing Peripheral Neuropathies; Bristol-Myers Squibb Monograph: New York, 2000, p. 12.
83. Cornblath, D.R.; McArthur, J.C.; Kennedy, P.G.; Witte, A.S.; Griffin, J.W. Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann Neurol. 1987, 21(1), 32–40.
84. Griffin, D.; McArthur, J.C. Soluble interleukin-2 receptor and soluble CD8 in serum and cerebrospinal fluid during human immunodeficiency virus-associated neurologic disease. J Neuroimmunol. 1990, 28, 97–109.
85. Misha, B.; Sommers, W.; Koski, C. Acute inflammatory demyelinating polyneuropathy in the acquired immunodeficiency syndrome. Ann Neurol. 1985, 18, 131–132.
86. Morgello, S.; Simpson, D.M. Multifocal cytomegalovirus demyelinative polyneuropathy associated with AIDS. Muscle Nerve. 1994, 17(2), 176–182.
87. Said, C. Multifocal neuropathy in HIV infection (abst.). In: Proceedings of the Seventh International Conference of HIV Infection; Padova: Italy, 1991, p 89.
88. herardi, G.R.; Lebargy, F.; Gaulard, P.; Mhiri, C.; Bernaudin, J.F.; Gray, F. Necrotizing vasculitis and HIV replication in peripheral nerves [letter]. N Engl J Med. 1989, 321(10), 685–686.
89. Engstrom, J.; Lewis, E.; McGuire, D. Cranial neuropathy and the acquired immunodeficiency syndrome. Neurology. 1991, 41(suppl 1), 374.
90. Berger, J.; Flaster, M.; Schatz, N. Cranial neuropathy heralding otherwise occult AIDS-related large cell lymphoma. J Clin Neurophysiol. 1993, 13, 113–118.
91. Stricker, R.; Sanders, K.; Owen, W. Mononeuritis multiplex associated with cryoglobulinemia in HIV infection. Neurology. 1992, 42, 2103–2105.
92. Roullet, E.; Asseurus, J.; Gozlan, J. Cytomegalovirus multifocal neuropathy in AIDS: analysis of consecutive patients. Neurology. 1994, 44, 2174–2182.
93. So, Y.; Olney, R. The natural history of mononeuritis multiplex and simplex in HIV infection. Neurology. 1991, 41(suppl 1), 375.
94. Cohen, B.J.; McArthur, J.C.; Grohman, S. Neurologic prognosis of cytomegalovirus polyradiculomyelopathy in AIDS. Neurology. 1993, 43, 493–499.
95. Anders, H.; Goebel, F. Cytomegalovirus polyradiculopathy in patients with AIDS. Clin Infect Dis. 1998, 27, 345–352.
96. Eidelberg, D.; Sotrel, A.; Vogel, H.; Walker, P.; Kleefield, J.; Crumpacker, C.S. Progressive polyradiculopathy in acquired immune deficiency syndrome. Neurology. 1986, 36(7), 912–916.
97. Miller, R.; Storey, J.; Greco, C. Ganciclovir in the treament of progressive AIDS-related polyradiculopathy. Neurology. 1990, 40, 569–574.
98. de, J.; J. Gans.; Portegies, P.; Tiessens, G. Therapy for cytomegalovirus polyradiculopathy in patients with AIDS. Treatment with ganciclovir. AIDS. 1990, 4, 421–425.
99. Gozlan, J.; El, M.; Baudrimont, M. Aprospective evaluation of clinical criteria and polymerase chain reaction assay of cerebrospinal fluid for the diagnosis of cytomegalovirus-related neurological diseases during AIDS. AIDS. 1995, 9, 253–260.
100. Shinkai, M.; Spector, S. Quantitation of human cytomegalovirus (HCMV) DNA in cerebrospinal fluid by competitive PCR in AIDS patients with different HCMV central nervous system diseases. Scan J Infect Dis. 1995, 27, 559–561.
101. Vogel, J.; Cinatl, J.; Lux, A. New PCR assay for rapid and quantitative detection of human cytomeglovirus in cerebrospinal fluid. J Clin Microbiol. 1996, 34, 482–483.
102. Lanska, M.; Lanska, D.J.; Schmidley, J. Syphilitic polyradiculopathy in an HIV-positive man. Neurology. 1988, 38, 1297–1301.
103. Leger, J.M.; Henin, D.; Belec, L.; Mercier, B.; Cohen, L.; Bouche, P.; Hauw, J.J.; Brunet, P. Lymphoma induced polyradiculopathy in AIDS: 2 cases. J Neurol. 1992, 239, 132–134.
104. Freeman, R.; Roberts, M.; Friedman, L. Autonomic function and human immunodeficiency virus infection. Neurology. 1990, 40, 575–580.
105. Shahmanesh, M.; Bradbeer, C.; Edwards, A. Autonomic dysfunction in patients with human immunodeficiency virus infection. Int J STD AIDS. 1991, 2, 419–423.
106. Craddock, C.; Pasvol, G.; Bull, R. Cardiorespiratory arrest and autonomic neuropathy in acquired immunodeficiency syndrome. Lancet. 1987, 2, 16–18.
107. Batman, P.A.; Miller, A.R.; Sedgwick, P.M.; Griffin, G.E. Autonomic denervation in jejunal mucosa of homosexual men infected with HIV. AIDS. 1991, 5(10), 1247–1252.
108. Chimelli, L.; Scaravilli, F. Morphological changes in the autonomic nervous system of patients with AIDS: Padova: Italy, 1991, 89.
109. Purba, J.S.; Hofman, M.A.; Portegies, P.; Troost, D.; Swaab, D.F. Decreased number of oxytocin neurons in the paraventricular nucleus of the human hypothalamus in AIDS. Brain. 1993, 116(4), 795–809.
110. Berman, A.; Espinoza, L.; Diaz, J. Rheumatic manifestations of human immunodeficiency virus infection. Am J Med. 1988, 85, 59–64.
111. Simpson, D.M.; Slasor, P.; Dafni, U.; Berger, J.; Fischl, M.A.; Hall, C. Analysis of myopathy in a placebo-controlled zidovudine trial. Muscle Nerve. 1997, 20(3), 382–385.
112. Simpson, D.M.; Citak, K.A.; Godfrey, E.; Godbold, J.; Wolfe, D.E. Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished? [see comments]. Neurology. 1993, 43(5), 971–976.
113. Chariot, P.; Ruet, E.; Authier, F.; Levy, Y.; Gherardi, R. Acute rhabdomyolysis in patients infected with human immunodeficiency virus. Neurology. 1994, 44, 1692–1696.
114. Dalakas, M.; Pezeshkpour, G.; Gravell, M.; Sever, J. Polymyositis associated with AIDS retrovirus. JAMA. 1986, 256, 2381–2383.
115. Iiia, I.; Nath, A.; Dalakas, M. Immunocytochemical and virological characteristics of HIVassociated inflammatory myopathies: similarities with seronegative patients. Ann Neurol. 1991, 29, 474–481.
116. Simpson, D.M.; Bender, A.N. Human immunodeficiency virus-associated myopathy: analysis of 11 patients. Ann Neurol. 1988, 24(1), 79–84.
117. Gonzalez, M.; Olney, R.; So, Y. Subacute structural myopathy associated with human immunodeficiency virus infection. Arch Neurol. 1988, 45, 585–587.
118. Seidman, R.; Peress, N.; Nuovo, G. In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids in skeletal muscle in patients with myopathy. Mod Pathol. 1994, 7, 369–375.
119. Bessen, L.J.; Greene, J.B.; Louie, E.; Seitzman, P.; Weinberg, H. Severe polymyositis-like syndrome associated with zidovudine therapy of AIDS and ARC. N Engl J Med. 1988, 318(11), 708.
120. Helbert, M.; Fletcher, T.; Peddle, B.; Harris, J.; Pinching, A. Zidovudine-associated myopathy. Lancet. 1988, 1, 689–690.
121. Gorard, D.; Henry, K.; Guiloff, R. Necrotizing myopathy and zidovudine. Lancet. 1988, 1, 1050–1051.
122. Gertner, E.; Thurn, J.; Williams, D. Zidovudine-associated myopathy. Am J Med. 1989, 6, 814–818.
123. Miller, K.D.; Cameron, M.; Wood, L.V.; Dalakas, M.C.; Kovacs, J.A. Lactic acidosis and hepatic steatosis associated with use of stavudine: report of four cases. Ann Intern Med. 2000, 133(3), 192–196.
124. Mokrzycki, M.H.; Harris, C.; May, H.; Laut, J.; Palmisano, J. Lactic acidosis associated with stavudine administration: a report of five cases. Clin Infect Dis. 2000, 30(1), 198–200.
125. Kuncl, R.; George, E. Toxic neuropathies and myopathies. Curr Opin Neurol. 1993, 6, 695–704.
126. Lane, R.; McLean, K.; Moss, J.; Woodrow, D. Myopathy in HIV infection: the role of zidovudine and the significance of tubuloreticular inclusions. Neuropathol Appl Neurobiol. 1993, 19, 406–413.
127. Morgello, S.; Wolfe, D.; Godfrey, E.; Feinstein, R.; Tagliati, M.; Simpson, D.M. Mitochondrial abnormalities in human immunodeficiency virus-associated myopathy. Acta Neuropathol. 1995, 90(4), 366–374.
128. Dalakas, M.C.; Illa, I.; Pezeshkpour, G.H.; Laukaitis, J.P.; Cohen, B.; Griffin, J.L. Mitochondrial myopathy caused by long-term zidovudine therapy [see comments]. N Engl J Med. 1990, 322(16), 1098–1105.
129. Panegyres, P.; Tan, M.; Kakulas, B. Necrotising myopathy and zidovudine. Lancet. 1988, 1, 1050–1051.
130. Espinoza, L.; Aguilar, J.; Espinoza, C.: Characteristics and pathogenesis of myositis in human immunodeficiency virus infection. Distinction from azidothymidine-induced myopathy. Rheum Dis Clin North Am. 1991, 107, 598–599.
131. Manji, H.; Harrison, M.; Round, J.; Jones, D.A.; Connolly, S.; Fowler, C.J.; Williams, I.; Weller, I.V. Muscle disease, HIV and zidovudine: the spectrum of muscle disease in HIVinfected individuals treated with zidovudine. J Neurol. 1993, 240(8), 479-488.
132. Till, M.; MacDonnell, K. Myopathy with human immunodeficiency virus type 1 (HIV-1) infection: HIB-1 or zidovudine. Ann Intern Med. 1990, 113, 492–494.
133. Mhiri, C.; Baudrimont, M.; Bonne, G.; Geny, C.; Degoul, F.; Marsac, C.; Roullet, E.; Gherardi, R. Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction. Ann Neurol. 1991, 29(6), 606–614.
134. Chalmers, A.C.; Greco, C.M.; Miller, R.G. Prognosis in AZT myopathy [see comments]. Neurology. 1991, 41(8), 1181–1184.
135. Simpson, D.; Godbold, J.; Hassett, J. HIV-associated myopathy, and the effects of zidovudine and prednisone. Clin Neuropathol. 1993, 12(suppl 1), S20.